Boston Trust Walden Corp Trims Stock Position in Applied Materials, Inc ...
π Boston Trust Walden Corp reduced its AMAT stake by 29.1% in Q1, selling 116,624 shares while retaining 284,603 shares valued at $97.3 million.
π Several smaller institutional investors increased positions in Q4, including Highline Wealth Partners (+48.7%) and Dogwood Wealth Management (+52.4%).
π¦ Hedge funds collectively own 80.56% of Applied Materials' outstanding stock as of the latest filings.
π Susquehanna Financial Group raised its price target to $900 with a 'positive' rating, while Cantor Fitzgerald set a target of $850.
π° Raymond James Financial established a $650 price objective in a recent research report dated June 10th.
π Senior Vice Presidents Timothy Deane and Omkaram Nalamasu sold shares worth approximately $20 million combined in late June.
π Applied Materials reported Q1 revenue of $7.91 billion, beating estimates of $7.68 billion by 3%.
π΅ The company posted earnings per share of $2.86, exceeding the consensus estimate of $2.68 by $0.18.
π Revenue grew 11.4% year-over-year to reach $7.91 billion during the reported quarter.
π― Q3 2026 earnings guidance is set between $3.16 and $3.56 per share by management.
π° A quarterly dividend of $0.53 per share was declared with an ex-dividend date of August 20th.
π Insider selling over the last 90 days totaled 278,088 shares worth $169.7 million.
- Applied Materials beat quarterly revenue expectations with $7.91 billion reported against a consensus of $7.68 billion.
- Earnings per share of $2.86 exceeded analyst estimates of $2.68, demonstrating strong profitability.
- Susquehanna Financial Group raised its price target to $900 and upgraded the rating to 'positive'.
- Cantor Fitzgerald increased its price target to $850 with an 'overweight' rating from analysts.
- Revenue grew 11.4% year-over-year, indicating sustained demand for semiconductor manufacturing equipment.
- The company achieved a high return on equity of 36.97% and a net margin of 29.31%.
- Analyst consensus remains 'Moderate Buy' with 27 buy ratings versus only 8 hold ratings.
- Management provided clear Q3 2026 guidance ranging from $3.16 to $3.56 EPS.
- Senior Vice Presidents Timothy Deane and Omkaram Nalamasu sold a combined total of 32,884 shares worth over $169 million in the last 90 days.
- Boston Trust Walden Corp significantly trimmed its position by 29.1% in the first quarter.